Madrigal Pharmaceuticals, Inc.

MDGL · Healthcare

$538.71

Capitalizzazione: 12.45B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Madrigal Pharmaceuticals, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

GlobeNewswire2 set 2026, 12:00

Madrigal Pharmaceuticals to Participate in the  2026 Cantor Global Healthcare Conference

Motley Fool25 ago 2026, 16:20

Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off

GlobeNewswire20 ago 2026, 20:05

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

MarketBeat15 ago 2026, 09:01

Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands